BioSpace News Archive

Model N, Inc. (NYSE: MODN), the leading provider of cloud revenue management solutions for Life Sciences and High Tech companies, plans to announce financial results for the third quarter fiscal year 2020 after market close on Tuesday, August 4, 2020.

National architecture, engineering and planning firm Bergmann has launched a new Science, Technology & Industry (STI) practice, providing an in-demand offering to companies in complex technical industries, including pharmaceuticals and biotechnology.

Eyelit Inc. announced top line revenue growth of over 25% for the first quarter of 2020 over the same period in 2019, despite lower services revenue due to COVID-19.

PLANEGG and MUNICH, GERMANY / ACCESSWIRE / July 14, 2020 / MorphoSys AG (FSE:MOR); Prime Standard Segment; MDAX & TecDAX; (NASDAQ:MOR) announced today that its licensee Janssen Research & Development, LLC (Janssen) announced the U.S. Food and Drug Administration (FDA) approval of Tremfya (R) (guselkumab) as a treatment for adult patients living with active psoriatic arthritis (PsA). Active PsA is a chronic progressive disease characterized by painful joints and skin inflammation. A

Advanced Data Systems RCM is pleased to announce that clients of its MedicsRCM service derive enhanced revenue from coronavirus-related claims.

APEX 3D™ marks the next generation in Total Ankle Arthroplasty, with advanced technologies such as porous 3D printed implants and Vitamin E infused highly cross-linked polyethylene. Paragon 28 con

Mid-Delaware Imaging announced that it has taken action after becoming aware of a ransomware event in which an unknown third party encrypted its systems.

Catalyst, an award-winning healthcare technology company, introduces MyMedTimes , the first fully automated, clinically managed mobile medication manager. 44% of Canadian adults , and 60% of Americans , live with at least one chronic condition, like heart disease and stroke, cancer, or diabetes, and medications play a key role in treatment. While the merits of taking medications as prescribed are well known, n

Envision Healthcare, a leading national medical group, announced today that the Envision Healthcare Center for Quality and Patient Safety has been awarded continued listing as a federally certified Patient Safety Organization (PSO) for an additional three years through the Agency of Healthcare Research and Quality.

IntraOp Medical Corporation announced today the delivery of its pre-clinical high dose rate electron beam linear accelerator to The Ohio State University Comprehensive James Cancer Center